News & Events
-
February 5, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed
Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Workshop (CPTR) 2018 Annual workshop originally scheduled for April 23-25, 2018. This workshop will be rescheduled later in 2018 to better align with deliverables from our programmatic efforts and alleviate some of the logistical challenges... -
January 22, 2018
Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker
Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) has issued a Letter of Support for measurement of glutamate dehydrogenase (GLDH) as a biomarker of hepatocellular liver injury. The letter was awarded to C-Path’s Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC)... -
January 22, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, et al. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology. 2018 Jan 22.
-
January 17, 2018
C-Path welcomes Kay Holcombe to its Board of Directors
January 17, 2018 TUCSON, Ariz., January 17, 2018 — The Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to its Board of Directors. Recently retired as Senior Vice President for Science Policy at the Biotechnology Innovation Organization (BIO), Ms. Holcombe brings to the Board her extensive experience in health care and regulatory policy, a... -
January 1, 2018
Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs
Gu, Yi-Zhong, Katerina Vlasakova, Sean P. Troth, Robert L. Peiffer, Herve Tournade, Flavia R. Pasello Dos Santos, Warren E. Glaab, and Frank D. Sistare. “Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-Induced Renal Tubular Injury in Tenofovir-Treated Cynomolgus Monkeys and Beagle Dogs.” Toxicologic Pathology, January 1, 2018, 192623318775023..